Search Results - "DELA CRUZ, Eduardo C"

Defined tuberculosis vaccine, Mtb72F/AS02A, evidence of protection in cynomolgus monkeys by Reed, Steven G, Coler, Rhea N, Dalemans, Wilifred, Tan, Esterlina V, DeLa Cruz, Eduardo C, Basaraba, Randall J, Orme, Ian M, Skeiky, Yasir A.W, Alderson, Mark R, Cowgill, Karen D, Prieels, Jean-Paul, Abalos, Rodolfo M, Dubois, Marie-Claude, Cohen, Joe, Mettens, Pascal, Lobet, Yves

“…The development of a vaccine for tuberculosis requires a combination of antigens and adjuvants capable of inducing appropriate and long-lasting T cell…”
Get full text

Limited Susceptibility of Cynomolgus Monkeys (Macaca fascicularis) to Leprosy after Experimental Administration of Mycobacterium leprae by WALSH, Gerald P, DELA CRUZ, Eduardo C, WALSH, Douglas S, ABALOS, Rodolfo M, TAN, Esterlina V, FAJARDO, Tranquilino T, VILLAHERMOSA, Laarni G, CELLONA, Roland V, BALAGON, Maria V, WHITE, Valerie A, SAUNDERSON, Paul R

“…Cynomolgus monkeys are a useful model for human tuberculosis, but susceptibility to M. leprae is unknown. A cynomolgus model of leprosy could increase…”
Get full text

A clinical trial of pefloxacin and ofloxacin in lepromatous leprosy by FAJARDO, Tranquilino T, VILLAHERMOSA, Laarni G, DELA CRUZ, Eduardo C, CELLONA, Roland V, BALAGON, Ma. Victoria F, ABALOS, Rodolfo M, GELBER, Robert H

“…A 2-month clinical trial of pefloxacin and ofloxacin in previously untreated multibacillary patients was conducted at the Leonard Wood Memorial Leprosy…”
Get full text

A clinical trial of ethionamide and prothionamide for treatment of lepromatous leprosy by Fajardo, Tranquilino T, Guinto, Ricardo S, Cellona, Roland V, Abalos, Rodolfo M, Dela Cruz, Eduardo C, Gelber, Robert H

“…In 1982-1984 we conducted a six-month clinical trial in 50 previously untreated lepromatous leprosy patients randomly assigned to directly observed monotherapy…”
Get more information

The Philippine cynomolgus monkey ( Macaca fasicularis ) provides a new nonhuman primate model of tuberculosis that resembles human disease by Walsh, Gerald P, Tan, Esterlina V, Dela Cruz, Eduardo C, Abalos, Rodolfo M, Villahermosa, Laarni G, Young, Leon J, Cellona, Roland V, Narareno, Jerome B, Horwitz, Marcus A

“…A nonhuman primate model of tuberculosis that closely resembles human disease is urgently needed. We have evaluated the Philippine cynomolgus monkey, Macaca…”
Get full text

Clofazimine therapy for lepromatous leprosy:a historical perspective by Fajardo, Tranquilino T., Abalos, Rodolfo M., Cruz, Eduardo C. dela, Villahermosa, Laarni G., Walsh, Douglas S., Cellona, Roland V., Balagon, Maria V., Tan, Esterlina V., Walsh, Gerald P.

Get full text

Parallel assessment of 24 monthly doses of rifampin, ofloxacin, and minocycline versus two years of World Health Organization multi-drug therapy for multi-bacillary leprosy by Villahermosa, Laarni G, Fajardo, Jr, Tranquilino T, Abalos, Rodolfo M, Cellona, Roland V, Balagon, Maria V, Dela Cruz, Eduardo C, Tan, Esterlina V, Walsh, Gerald P, Walsh, Douglas S

“…Monthly doses of rifampin, ofloxacin, and minocycline (ROM) are expected to be effective treatment for multi-bacillary leprosy. Patients with MB leprosy…”
Get more information

Clinical and histologic features of skin lesions in a cynomolgus monkey experimentally infected with mycobacterium ulcerans (Buruli ulcer) by intradermal inoculation by Walsh, Douglas S, Dela Cruz, Eduardo C, Abalos, Rodolfo M, Tan, Esterlina V, Walsh, Gerald P, Portaels, Françoise, Meyers, Wayne M

“…Buruli ulcer, caused by Mycobacterium ulcerans, is a destructive infection that most commonly affects the skin. Animal models for Buruli ulcer include guinea…”
Get more information

Long-term efficacy of 2 year WHO multiple drug therapy (MDT) in multibacillary (MB) leprosy patients by Cellona, Roland V, Balagon, Maria F V, dela Cruz, Eduardo C, Burgos, Jasmin A, Abalos, Rodolfo M, Walsh, Gerald P, Topolski, Richard, Gelber, Robert H, Walsh, Douglas S

“…Relapse rate estimates after 2 year WHO multiple drug therapy (MDT) in multi-bacillary (MB) leprosy vary. Between 1987 and 1994, 500 MB leprosy patients…”
Get more information

Defined Tuberculosis Vaccine, Mtb72F/ASO2A, Evidence of Protection in Cynomolgus Monkeys by Reed, Steven G., Coler, Rhea N., Dalemans, Wilifred, Tan, Esterlina V., DeLa Cruz, Eduardo C., Basaraba, Randall J., Orme, Ian M., Skeiky, Yasir A. W., Alderson, Mark R., Cowgill, Karen D., Prieels, Jean-Paul, Abalos, Rodolfo M., Dubo, Marie-Claude, Cohen, Joe, Mettens, Pascal, Lobet, Yves, Bloom, Barry R.

“…The development of a vaccine for tuberculosis requires a combination of antigens and adjuvants capable of inducing appropriate and long-lasting T cell…”
Get full text

Detection of new leprosy cases at a walk‐in skin clinic in Cebu City, Philippines, highlights surveillance: Roberto Cortés Franco, MD, Editor by Balagon, Maria V. F., Cellona, Roland V., Fajardo, Tranquilino T., Abalos, Rodolfo M., Walsh, Douglas S., Villahermosa, Laarni G., Tan, Esterlina V., dela Cruz, Eduardo C., Walsh, Gerald P.

Get full text

Detection of new leprosy cases at a walk-in skin clinic in Cebu City, Philippines, highlights surveillance by Balagon, M V, Cellona, R V, Fajardo, Jr, T T, Abalos, R M, Walsh, D S, Villahermosa, L G, Tan, E V, dela Cruz, E C, Walsh, G P

Get full text